I had been asking myself a question for quite a while - Given that the patent on a method of CHS synthesis was granted in July of 2024, why hasn't the company made it more publicly known? But if all the suggested work on Endurion really is in process, AND we accept that CHS is an integral component of Endurion chemistry - then it might make sense that a patent award isn't converted into a press release if such a patent is part of something else they aren't talking about.
So then my question might be who is paying for all this work, and was the failed DKME deal a blow to the plan?
Market Data 
Markets 
AI
